⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28199784 | 0.74 | — | — | |
| SCHEMBL14692211 | 0.71 | — | — | |
| SCHEMBL2896396 | 0.71 | — | — | |
| SCHEMBL2880294 | 0.71 | — | — | |
| SCHEMBL26468788 | 0.69 | — | — | |
| SCHEMBL1370603 | 0.68 | SPHK1 (0.46) | — | |
| SCHEMBL1370602 | 0.68 | SPHK1 (0.46) | — | |
| SCHEMBL26468771 | 0.66 | ELANE (0.34) | — | |
| SCHEMBL26468519 | 0.65 | CHRNB2 (0.34) | — | |
| SCHEMBL25257861 | 0.64 | SPHK1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6872740-B2 | Use of 2-amino-4-heteroarylethyl-thiazoline derivatives as inhibitors of inducible no-synthase | AVENTIS PHARMA S.A. (FR) | 2005-03-29 | — | — | US | disclosed |
| US-20030225140-A1 | 4-(heteroarylethyl)-4,5-dihydro-1,3-thiazol-2-ylamine or salt, useful for treating an illness, which involves an abnormal production of nitric oxide (NO) by induction of an inducible NO-synthase | AVENTIS PHARMA S.A. (FR) | 2003-12-04 | — | — | US | disclosed |